US20050049634A1 - Medical closure device - Google Patents
Medical closure device Download PDFInfo
- Publication number
- US20050049634A1 US20050049634A1 US10/636,791 US63679103A US2005049634A1 US 20050049634 A1 US20050049634 A1 US 20050049634A1 US 63679103 A US63679103 A US 63679103A US 2005049634 A1 US2005049634 A1 US 2005049634A1
- Authority
- US
- United States
- Prior art keywords
- distal section
- section
- opening
- distal
- configuration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00659—Type of implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00902—Material properties transparent or translucent
- A61B2017/00911—Material properties transparent or translucent for fields applied by a magnetic resonance imaging system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00982—General structural features
- A61B2017/00986—Malecots, e.g. slotted tubes, of which the distal end is pulled to deflect side struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0419—H-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
- A61B2017/3482—Means for supporting the trocar against the body or retaining the trocar inside the body inside
- A61B2017/3484—Anchoring means, e.g. spreading-out umbrella-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
- A61B2017/3482—Means for supporting the trocar against the body or retaining the trocar inside the body inside
- A61B2017/3484—Anchoring means, e.g. spreading-out umbrella-like structure
- A61B2017/3486—Balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
- A61B2017/3492—Means for supporting the trocar against the body or retaining the trocar inside the body against the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
Definitions
- the invention generally pertains to medical closure devices, such as medical devices for closing an opening in tissue bounding a cavity in the anatomy of a patient.
- tissue such as a membrane or vessel wall within the anatomy of the patient.
- an opening such as an incision or puncture, in created in the dural membrane of a patient to gain access to anatomies therein.
- the dural membrane covers the inside of the cranium and the spinal canal, and forms an enclosed system that contains other membranes, the brain, spinal cord, and Cerebrospinal fluid (C.S.F.).
- the invention provides several alternative designs, structures, assemblies, treatment methods and/or methods of manufacturing medical closure devices adapted and/or configured for closing an opening, for example, an incision or a puncture in the tissue of a patient, for example, the dural membrane of a patient.
- FIG. 1 is a schematic cross sectional side view of a closure device in a first, unexpanded configuration
- FIG. 2 is a schematic cross sectional side view of the closure device of FIG. 1 , inserted into an opening in the dural membrane of an adult human being using an elongated insertion device;
- FIG. 3 is a schematic cross sectional side view of the closure device of FIG. 2 , wherein the distal portion of the closure device is being engaged by the insertion device such that it is partially expanded;
- FIG. 4 is a schematic cross sectional side view of a the closure device of FIG. 3 , wherein the distal portion of the closure device has been fully expanded to close the opening in the dural membrane;
- FIG. 5 is a schematic cross sectional side view of an alternative embodiment of a closure device in a first, unexpanded configuration
- FIG. 6 is a schematic cross sectional side view of the closure device of FIG. 5 , wherein the distal portion of the closure device has been fully expanded to close the opening in the dural membrane.
- Weight percent, percent by weight, wt %, wt-%, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the weight of the composition and multiplied by 100.
- certain aspects of the invention may be applicable for use in closing tissue such as other anatomical tissues or membranes or walls within the anatomy, for example, within the vasculature, abdominal (i.e. to close an incision made during a laparascopy or laparotomy) or other portions of the anatomy.
- closure device is described in terms of different sections, the device, or multiple sections thereof, may be made as a single element, for example, through extrusion, molding, casting, and the like. Variations in sizes and flexibility, as well as the inclusion of rigid or semi-rigid materials, should not be interpreted as requiring a certain method or type of construction. While the present description is written largely in terms of use in a human patient, the present invention may also be used with other organisms, for example in veterinary procedures by applying adaptations suited to a particular organism's anatomy.
- FIG. 1 is a diagrammatic cross sectional side view of one example embodiment of a closure device 10 adapted and/or configured for closing an opening in tissue bounding a cavity in the anatomy of a patient.
- the device 10 includes a body member, such as an elongated tubular member 12 having a distal end 14 and a proximal end 16 .
- the tubular member 12 includes a distal section 18 an intermediate section 19 , and a proximal section 20 , and defines an inner lumen 22 extending there through.
- the tubular member 12 , and the inner lumen 22 defined thereby, extend generally along a longitudinal axis, X.
- the tubular member 12 defines an outer surface 24 having an outer perimeter, and an inner surface 26 having an inner perimeter.
- the outer surface 24 includes a distal portion 24 a corresponding to the distal section 18 , an intermediate portion 24 b corresponding to the intermediate section 19 , and a proximal portion 24 c corresponding to the proximal section 20 .
- the distal end 14 of closure device 10 may be angled or tapered, or may be generally flat, as shown or otherwise adapted to facilitate insertion.
- tubular body member 12 may include any of a broad variety of cross sectional shapes, often dependent upon the shape and size of the opening in the tissue to be closed or sealed, and/or upon the shape and size of other devices that may be used with the closure device 10 .
- the structure, or portions thereof may include any of a broad variety of cross-sectional shapes, for example, circle, oval, square, rectangle, or other polygon or like shapes, or combinations thereof.
- sections 18 , 19 , and 20 and the lumen 22 are shown as including generally constant outer and inner diameters along the length thereof, in other embodiments, these diameters may change or taper along the length of each segment 18 , 19 , and 20 or along the length of the lumen 22 .
- the device 10 also includes a first non-return valve 36 disposed in the lumen 22 at proximal end 16 , and a second non-return valve 38 disposed in the lumen 22 at the distal end 14 .
- the non-return valves 36 and 38 are adapted so that a needle, trochar, guidewire, catheter, or other such device or structure may be introduced through the valves 36 and 36 without allowing substantial fluid within the lumen of closure device to escape, and, conversely, without allowing foreign particles to enter the lumen 22 of closure device 10 .
- the non-return valve may be a hemostatic valve, membrane, or the like.
- the non-return valves may be adapted and/or configured to include ports that can be accessed multiple times.
- the proximal section 20 includes a proximal portion 28 disposed adjacent the proximal end 16 of the tubular member 12 .
- the proximal portion 28 defines the outer surface portion 24 c that has an outer perimeter.
- the intermediate section 19 of the tubular member defines outer surface portion 24 b that has an outer perimeter, and the outer surface portion 24 c has a greater outer perimeter than the outer surface portion 24 b .
- the proximal portion 28 is bigger around than the intermediate section 32 .
- the proximal portion 28 defines a distal side surface 25 a and a proximal side surface 25 b .
- the distal side surface 25 a forms a stepped up or shoulder area 27 where the intermediate section 19 and proximal portion 28 meet.
- the proximal portion 28 can be a separate member that is attached or connected to the outer surface 24 of the of the tubular member 12 at the proximal section 20 , or can be a widening or expansion in unitary construction with the tubular member 12 to created the increased outer perimeter.
- the widened proximal portion 28 is adapted and/or configured such that the outer surface 24 c has an outer perimeter that is larger than an outer perimeter of the opening in the tissue of the patient that is to be closed.
- the widened proximal portion 28 can be adapted and/or configured to acts as a stop and/or as a sealing portion that contacts the outer surface of the tissue in which the opening is being closed or sealed.
- the intermediate section 19 of the tubular member 12 extends distally of the proximal portion 28 , and as indicated above, includes an outer surface portion 24 b that has an outer perimeter that is smaller than the outer perimeter of the proximal portion 28 .
- the intermediate section 19 can be a separate member that is attached or connected to the proximal section 20 , or can be of unitary construction with the proximal section 20 .
- the intermediate section 19 can have an outer surface 32 that has an outer perimeter that is sized and/or configured for insertion into the opening in the tissue to be closed or sealed.
- the intermediate section 19 is adapted and/or configured to extend within the opening in the tissue to be closed or sealed between the widened proximal portion 28 and the distal section 18 .
- the distal section 18 of the tubular member 12 extends distally of the intermediate section 19 , and also includes an outer surface portion 24 c that has an outer perimeter.
- the distal section 18 can be a separate member that is attached or connected to the intermediate section 19 , or can be of unitary construction with the intermediate section 19 .
- the distal section 20 includes at least a portion thereof that is adapted and/or configured to be radially expandable from a first configuration, wherein the outer surface portion 24 c of the distal section 18 is sized for insertion into and through the opening in the tissue to be closed, to a second, radially expanded configuration, wherein at least a portion of the outer surface portion 24 c of the distal section 18 has a larger outer perimeter than when in the first configuration.
- the distal section 18 of the tubular member 12 when in the first, unexpanded configuration, is adapted and/or configured to be inserted through the opening in the tissue to be closed or sealed, and into the interior of the opening in the tissue. Thereafter, the distal section 18 can be expanded into the second, expanded configuration, wherein it can be adapted and/or configured to act as a stop and/or as a sealing portion that contacts the inner surface of the tissue in which the opening is being closed or sealed.
- the distal section 18 is shown in a first, or unexpanded configuration.
- the distal section 18 is configured such that the radial expansion of at least a portion of the distal section can be achieved through the application of sufficient compressive longitudinal force to the distal section 18 .
- the distal section 18 includes at least one area 30 along the length thereof that has a reduced column strength relative to other portions of the distal section 18 .
- Some embodiments may include multiple areas of reduced column strength. Such areas 30 of reduced column strength are adapted to bend or fold in an outward direction relative to the longitudinal axis, such that the outer surface 24 a expands radially outward when a sufficient compressive longitudinal force is applied to the distal section 18 .
- the area 30 has a weaker column strength than adjacent areas, and as such, it is adapted to give, and/or bend in an outward direction when the distal section 18 is placed under sufficient compressive force. This giving and/or bending in an outward direction resulting in radial outward expansion of at least a portion of the distal section 18 allows the distal section 18 to transition from the unexpanded to the expanded configuration.
- the area 30 of reduced column strength can be achieved or created in any of a number of ways.
- the inner surface 26 of the distal section 18 includes a cylindrical portion having a reduced wall thickness to create the area 30 of reduced column strength.
- an area of reduced column strength can be achieved through other means or mechanisms, for example, other structure, such as one or more groove, channel, furrow, notch, cut, fold, crease, wrinkle, ridge, kink, or other such structure defined in the wall of the distal section 18 that may result in reduced column strength, or a propensity to fold outwardly under compressive force.
- an area 30 having reduced column strength or having a propensity to fold outwardly under compressive force may be created by using materials in such areas having different properties relative to the remainder of the distal section 18 .
- such an area may be created by using a material having a different modulus of elasticity from the remaining portions of the distal section 18 .
- such an area may include or be made of material having a reduced elastic modulus (i.e., increased flexibility) relative to other portions of the distal section 18 , and would therefore have reduced column strength, and/or have a propensity to fold outwardly under compressive force.
- Some embodiments may also include a binding mechanism to help maintain the distal section 18 in the expanded configuration.
- a binding material 32 such as an adhesive or other bonding agent or mechanism may be disposed on the inner surface 26 of the distal section 18 .
- the binding material 32 may be disposed on either side, or on both sided of the area 30 such that when the area 30 of reduced column strength bends or folds in an outward direction, adjacent portions of the inner surface 26 about the fold can be bound together to help maintain the expanded configuration.
- FIG. 2 is a diagrammatic side view of the closure device 10 of FIG. 1 , in the unexpanded first configuration, inserted into an opening 50 in tissue 52 of a patient.
- the opening 50 may be in the dural membrane 52 of a patient.
- the dural membrane 52 forms an enclosed system that contains other membranes, the brain, spinal cord, and Cerebrospinal fluid (C.S.F.).
- the dural membrane 52 is located beneath other tissue 54 , and encloses and defines a cavity 56 , for example, the subarachnoid space of a patient.
- the dural membrane 52 includes an outer surface 53 and an inner surface 55 .
- Some examples of procedures and devices that involve creating an opening in the dural membrane are disclosed copending U.S. patent application Ser. No.: 10/328,560 filed on Dec. 23, 2002, entitled METHODS AND APPARATUSES FOR NAVIGATING THE SUBARACHNOID SPACE; Ser. No. 09/905,670 filed on Jul. 13, 2001, entitled METHODS AND APPARATUSES FOR NAVIGATING THE SUBARACHNOID SPACE; Ser. No. 10/328,349 filed on Dec. 23, 2002, entitled INTRODUCER SHEATH; and Ser. No. 10/328,373, filed on Dec. 23, 2002, entitled GUIDE CATHETER FOR INTRODUCTION INTO THE SUBARACHNOID SPACE AND METHODS OF USE THEREOF, all of which are incorporated herein by reference.
- the closure device 10 is shown inserted through the tissue 54 above the dural membrane 52 , and into the opening 50 .
- the distal section 18 and the intermediate section 19 are sized to extend through or within the opening 50 , while the widened proximal portion 28 is adapted and/or configured such that the outer surface 24 c has an outer perimeter that is larger than an outer perimeter of the opening 50 .
- the distal section 18 is shown in the unexpanded first configuration extending into the subarachnoid space 56 .
- the intermediate section 19 is shown as extending within the opening 50 .
- the proximal section 20 including proximal portion 28 , is shown on the outside, or proximal side, of the opening 50 .
- the distal side surface 25 a of the widened proximal portion 28 makes contact with the outer surface 53 of the dural membrane 52 about the opening 50 .
- the closure device 10 can be inserted into the opening 50 using any suitable device or mechanism.
- an insertion device such as a needle 60 , trochar, or the like, can be disposed into the lumen 22 of the device 10 .
- the needle 60 or other device, can then be used to insert the closure device 10 into the opening 50 , and the device 10 can be advanced into the opening 50 until the widened proximal portion 28 makes contact with the outer surface 53 of the dural membrane 52 .
- the needle 60 may be inserted through both of the non-return valves 36 and 38 , which can be adapted to provide a frictional fit with the needle 60 such that insertion can be made with relatively little or no movement of the device 10 relative to the needle 60 .
- the needle 60 or other insertion device can be adapted or configured to include properties or structures that facilitate insertion and/or cooperation with the device 10 .
- some embodiments may include a tapered or sharpened distal tip 62 to facilitate insertion, or protrusions 61 on the outer surface thereof that are adapted to create or provide additional frictional fit or engagement with the valves 36 and 38 .
- the device can be inserted into the opening 50 using any suitable insertion instrument, technique or apparatus.
- a guidewire, catheter, or the like may be disposed such that it extends through the opening 50 in the dural membrane 52 and into subarachnoid space 56 , and may be used to guide or facilitate the introduction of closure device 10 .
- the needle 60 can begin to be withdrawn, as shown in FIG. 3 , for example, along longitudinal axis X. In some embodiments, it may be necessary during withdrawal of the needle 60 to apply pressure to the widened proximal portion 28 such that it maintains a desired position, for example, in contact with the outer surface 53 of the dural membrane 52 about the opening 50 .
- the needle 60 can engage structure in the distal section 18 of the tubular member 12 .
- the needle 60 through friction, engages the distal non-return valve 38 .
- the protrusions 61 on the needle 60 can aid in the frictional engagement of the distal non-return valve 38 , or may in some embodiments provide for an interference fit with the distal non-return valve 38 .
- a compressive longitudinal force is applied to the walls of the tubular member 12 due to the frictional or interference engagement of the needle 60 with the distal non-return valve 38 .
- the compressive longitudinal force is sufficient to cause the areas 30 of reduced column strength on the distal section 18 to bend or fold in an outward direction relative to the longitudinal axis X. As the bend or fold is created, the outer surface 24 a expands radially outward.
- the longitudinal force and the bending and/or folding of the distal section 18 about the area 30 creates a proximal region or fold 65 in the distal section 18 that is pulled toward the inner surface 55 of the dural membrane 52 . Additionally, a distal region or fold 63 in the distal section 18 is created, and the distal region 63 is pulled toward the proximal region 65 .
- FIG. 4 wherein the distal section 18 is shown in a fully expanded configuration.
- the proximal region or fold 65 in the distal section 18 is pulled against the inner surface 55 of the dural membrane 52 .
- the distal region or fold 63 is pulled toward the proximal region 65 , and the adhesive material 32 can act to bind the two regions 63 and 65 together to help maintain the expanded configuration.
- the outer surface 24 a of the distal region has expanded radially outward such that it has an outer perimeter that is greater than the outer perimeter of the opening 50 in the dural membrane 52 . As such, the opening 50 has been closed by the closure device 10 .
- the closure device is maintained in position by the radially expanded distal section engaging the inner surface 55 of the dural membrane, and the widened proximal portion 28 engaging the outer surface 53 of the dural membrane 52 about the opening 50 .
- the intermediate section 19 extends through the opening, and interconnects the distal section 18 and the proximal portion 28 .
- the closure device 10 acts to at least substantially close or seal the opening 50 .
- a binding mechanism such as an adhesive type material, may b e used on the outer surface 24 a of the distal section 18 .
- an adhesive material could be included on the outer surface of the proximal region 65 of the distal section 18 . At least a portion of the outer surface of this region 65 may come into contact with the inner surface 55 of the dural membrane, and an adhesive material applied thereto could provide for a bond between the proximal region 65 and the inner surface 55 of the dural membrane. Such a bond may help maintain the closure device 10 in the expanded configuration, and may additionally help to seal the opening.
- a binding mechanism such as an adhesive type material, may be used on an outer surface of the proximal portion 28 .
- an adhesive material may be applied to the distal side surface 25 a and could provide for a bond between the proximal portion 28 and the outer surface 53 of the dural membrane. Such a bond may help maintain the closure device 10 in position relative to the opening, and may additionally help to seal the opening 50 . It is contemplated that in at least some such embodiments, the adhesive material used would be compatible with the tissue or anatomy in which it is being used.
- the closure device 10 when the closure device 10 is in place within the anatomy, it can be used as a port for introduction of other devices and/or structures.
- additional structures may be introduced into the cavity defined by the tissue, (such as the subarachnoid space in the case of the dural membrane), through the lumen 22 within the closure device 10 .
- a guidewire, catheter, introducer sheath, needle, trochar, endoscopes, flush tubes, and other devices, or the like may be advanced through the lumen 22 via the valves 36 and 38 and into the cavity 56 .
- Such additional devices may then be navigated or advanced within the cavity 56 , or may take samples of fluid, such as CSF, or may introduce material, such as drugs, marker fluid, or the like, into the cavity 56 .
- the closure device 10 including for example the non-return valves 36 and 38 may be adapted and/or configured to be accessed multiple times by one or more devices, and in some examples, can remain in place for a period of time to act as an access port to the anatomy.
- the embodiments shown include a single lumen 22
- other embodiments may include multiple lumens.
- Such an embodiment can be, for example, adapted for use with or introduction of multiple devices, such as guidewires, catheters and the like, through the separate lumens.
- the closure device 10 may act as a platform for additional structures or devices.
- the distal section 18 may include a transducer, for example, a microsensor embedded into a wall of the closure device 10 for sensing the temperature, pressure, body chemistry or the like inside the cavity 56 , such as the subarachnoid space, or other anatomy in which the device 10 is used.
- a transducer may be coupled to an electric (i.e. a wire) or optic connection running along, through, or embedded into the tubular member 12 from a distal location to a proximal location.
- such a transducer may be a wireless sensor, for example, a wireless resonant pressure or temperature sensor.
- the transducer may be included for determining a physiologic property during an operation, or to assist in diagnosis. Any of a wide variety of small sensing devices may be used as a transducer including, for example, resonant sensors, micromachined sensors, or even more conventional sensors which, though relatively bulky, may be incorporated into or attached to the closure device 10 .
- the size and dimensions of the closure device 10 is greatly dependent upon the size and dimensions of the particular anatomy in which it is intended for use, and the size of the opening in the anatomy that is being closed.
- the lengths and diameters of different segments of the closure device 10 may thus be adapted for particular usages, and can vary greatly.
- the outer diameter and length of the intermediate section 19 and the distal section 18 in the unexpanded configuration may be adapted for entry into a particular opening size in a particular anatomy, as the allowed outer diameters and length available and necessary for entry may vary from one particular opening size and anatomy to the next, as well as from one patient to the next.
- the length and outer diameter of the proximal section, including the proximal portion 28 , and the distal section 18 in an expanded configuration may also vary greatly, depending upon the size of the opening to be closed, and the available space in the anatomy.
- the device can have dimensions that are particularly adapted and/or configured for closing an opening in the dural membrane.
- the dimensions of the lumen 22 and of the non-return valves 36 and 38 may vary greatly, depending upon the dimensions of the other components or sections, and upon the dimensions of other devices, if any, that are intended for use with the device.
- proximal section 20 With respect to the proximal section 20 , it is possible to have an even larger lumen 22 within that section to make the lumen more easily accessed and/or passed. For example, because the proximal section 20 is not inserted into the opening 50 the outer diameter of the proximal section 20 is not as subject to the anatomical limits of a patient into whom the device is inserted, and hence there are fewer limits on the inner lumen 22 diameter in the proximal section 20 , either.
- closure device 10 A wide variety of materials may be used to make the closure device 10 , or sections or portions thereof.
- the closure device 10 including the tubular body member 12 , the proximal member 28 , or portions thereof, can be manufactured from any suitable material to impart the desired characteristics.
- suitable materials can include, for example, polymers, metal-polymer composites, metals, metal alloys, or the like, or combinations or mixtures thereof.
- suitable materials include, but are not limited to, polymers such as polyoxymethylene, polybutylene terephthalate, polyether block ester, polyether block amide, fluorinated ethylene propylene, polyethylene, polypropylene, polyvinylchloride, polyurethane, polytetrafluoroethylene (PTFE), polyether-ether ketone, polyimide, polyamide, polyphenylene sulfide, polyphenylene oxide, polysufone, nylon, perfluoro(propyl vinyl ether), polyether-ester, polymer/metal composites, etc., or mixtures, blends or combinations thereof.
- polymers such as polyoxymethylene, polybutylene terephthalate, polyether block ester, polyether block amide, fluorinated ethylene propylene, polyethylene, polypropylene, polyvinylchloride, polyurethane, polytetrafluoroethylene (PTFE), polyether-ether ketone, polyimide, polyamide, poly
- polyether block ester is available under the trade name ARNITEL
- polyether block amide is available under the trade name PEBAX®, from ATOMCHEM POLYMERS, Birdsboro, Pa.
- the polymer material of certain sections of the closure device 10 can be blended with a liquid crystal polymer (LCP).
- LCP liquid crystal polymer
- the mixture can contain up to about 5% LCP. This has been found to enhance torqueability in some embodiments.
- suitable metals and metal alloys include nickel-titanium alloy, such as linear elastic or superelastic nitinol, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, stainless steel, such as 304 v stainless steel; or the like; or other suitable material.
- the closure device 10 for example the tubular body member 12 and the proximal member 28 , can be made of unitary construction, or can be made up of a plurality of tubular segments coupled together, each segment being made of materials having the same or different properties.
- different portions or sections of the device 10 can include or be made of materials, or have structure that renders them more flexible or softer than other portions of the device 10 .
- the distal section 18 may be more flexible or softer than at least a part of the intermediate or proximal sections 19 and 20 .
- the distal section 18 can be less flexible or harder than at least a part of the of the intermediate or proximal sections 19 and 20 .
- the closure device 10 can be made of a single layer of material, or a plurality of layers.
- the tubular body member 12 and the proximal member 28 can include one or more layers disposed or stacked on top of one another.
- the different layers may be made of the same material or different materials.
- one of the layers may be made of a generally less flexible polymer than the other(s).
- one or more of the layers may be made of or doped with an indicator material to enhance imaging.
- one of the layers may act as a support layer, and can include, for example, support structure, such as a braid, coil, or other such structures.
- the closure device 10 including the tubular body member 12 and the proximal member 28 can be constructed using any appropriate technique, for example, by extrusion, a heat bonding process, casting, molding, and the like.
- the device 10 may be provided with an initial rigid shape, but may be re-shaped by a physician before insertion to better match the anatomy of the patient.
- the distal section 18 , intermediate section 19 , and/or proximal section 20 , or portions thereof may be made of a material such as PTFE that is rigid, but may be heated and re-shaped, so that once re-cooled, the distal section, intermediate section 18 , and/or proximal section 20 will retain the new shape.
- the closure device, or portions thereof can be made of or include a lubricious material, for example tetrafluoroethylene, or a copolymer of tetrafluoroethylene with perfluoroalkyl vinyl ether (more specifically, perfluoropropyl vinyl ether or perfluoromethyl vinyl ether), or the like.
- a lubricious material for example tetrafluoroethylene, or a copolymer of tetrafluoroethylene with perfluoroalkyl vinyl ether (more specifically, perfluoropropyl vinyl ether or perfluoromethyl vinyl ether), or the like.
- the closure device, or sections or portions thereof can include a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of the device 10 , or within the lumen 22 of the device.
- Hydrophobic coatings such as fluoropolymers provide a dry lubricity which can improve insertion, and when disposed in the lumen 22 , and improve insertions of other devices therethrough.
- Lubricious coatings can also aid in this manner.
- Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof.
- Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility.
- the distal section 18 (as well as the rest of closure device 10 , as desired) may also include one or more markers or a coating to enhance its imaging visibility, for example MRI visibility, and, for some embodiments, may include radiopaque materials or other high visibility materials adapted for use with other imaging technologies, such as fluoroscopy.
- the closure device may be made of material and structure compatible with certain imaging techniques, for example an MRI scanning compatible material or structure.
- ferrous materials such as some stainless steel alloys often used to provide braided reinforcement to catheters, are typically magnetically responsive, and are generally not used in conjunction with MRI equipment, or are provided with structure that would render them compatible with MRI equipment.
- other embodiments may not include materials that are currently MRI compatible.
- FIG. 5 is a side view of another illustrative embodiment showing a closure device 110 , this time including some alterations to the tubular member 112 .
- the device 110 also includes a body member, such as an elongated tubular member 112 having a distal end 114 and a proximal end 116 .
- the tubular member 112 includes a distal section 118 an intermediate section 119 , and a proximal section 120 , and defines an inner lumen 122 extending there through.
- the tubular member 112 , and the inner lumen 122 defined thereby, extend generally along a longitudinal axis, X.
- the tubular member 112 defines an outer surface 124 having an outer perimeter, and an inner surface 126 having an inner perimeter.
- the outer surface 124 includes a distal portion 124 a corresponding to the distal section 118 , an intermediate portion 124 b corresponding to the intermediate section 119 , and a proximal portion 124 c corresponding to the proximal section 120 .
- the device 110 also includes a first non-return valve 136 disposed in the lumen 122 at proximal end 116 , and a second non-return valve 138 disposed in the lumen 122 at the distal end 114 .
- the proximal section 120 and intermediate section 119 are configured substantially similar to the proximal section 20 and intermediate section 19 embodiment shown in FIG. 1-4 .
- the proximal section 120 includes a proximal portion 128 defining the outer surface portion 24 c that has an outer perimeter that is greater than the outer perimeter of outer surface portion 24 b .
- the proximal portion 128 defines a distal side surface 125 a and a proximal side surface 125 b , and a stepped up or shoulder area 127 .
- the distal segment 118 in this embodiment includes a plurality of areas 130 along the length thereof that have a reduced column strength relative to other portions of the distal section 118 .
- Such areas 130 of reduced column strength are adapted to bend or fold in an outward direction relative to the longitudinal axis, such that the outer surface 124 a expands radially outward when a sufficient compressive longitudinal force is applied to the distal section 118 .
- This giving and/or bending in an outward direction resulting in radial outward expansion of at least a portion of the distal section 118 allows the distal section 118 to transition from an unexpanded to an expanded configuration.
- the areas 130 of reduced column strength are created by reducing the wall thickness on a portion of the inner surface 126 of the distal section 118 .
- the closure device 110 has been inserted into an opening 50 in tissue 52 of a patient, for example, an opening 50 in the dural membrane 52 of a patient.
- a needle 60 was used for insertion, and the needle 60 is being withdrawn, such that the distal section 118 is in a partially expanded configuration.
- the needle 60 engages the distal non-return valve 138 , and a compressive longitudinal force is applied to the walls of the tubular member 112 .
- the compressive longitudinal force is sufficient to cause the areas 130 of reduced column strength to bend or fold in an outward direction relative to the longitudinal axis X. As the bends or folds are created, the outer surface 24 a expands radially outward.
- the longitudinal force and the bending and/or folding of the distal section 118 about the areas 30 creates a plurality of folds 165 , each fold 165 being proximal to an adjacent area 130 .
- the folds 165 are pulled in a proximal direction.
- the proximal—most fold 165 is pulled toward the inner surface 55 of the dural membrane 52 .
- the longitudinal force creates a plurality of folds 163 , each fold 163 being distal to an adjacent area 130 .
- Each of the folds 163 is pulled toward the associated proximal fold 165 about the areas 130 .
- FIG. 6 wherein the distal section 118 is shown in a fully expanded configuration.
- this fully expanded configuration at least a portion of the most proximal fold 165 is pulled against the inner surface 55 of the dural membrane 52 .
- each of the folds 163 is pulled toward the associated folds 165 about each of the areas 130 .
- An adhesive material 132 can act to bind each of the two folds 163 and 165 together to help maintain the expanded configuration.
- the outer surface 124 a of the distal region 118 has expanded radially outward such that it has an outer perimeter that is greater than the outer perimeter of the opening 50 in the dural membrane 52 . As such, the opening 50 has been closed by the closure device 110 .
- the closure device is maintained in position by the radially expanded distal section 118 engaging the inner surface 55 of the dural membrane, and the widened proximal portion 128 engaging the outer surface 53 of the dural membrane 52 about the opening 50 .
- the intermediate section 119 extends through the opening 50 , and interconnects the distal section 118 and the proximal portion 128 .
- the closure device 110 acts to at least substantially close or seal the opening 50 .
Abstract
Description
- The invention generally pertains to medical closure devices, such as medical devices for closing an opening in tissue bounding a cavity in the anatomy of a patient.
- It is sometimes necessary in diagnosis and/or treatment of disease to gain access to, or navigate within certain anatomies of a patient. During such procedures, it is sometimes necessary to penetrate certain tissue that bounds a cavity in the anatomy of a patient. For example, certain treatment or operations require that an opening be created in tissue such as a membrane or vessel wall within the anatomy of the patient. For example, in some procedures, an opening, such as an incision or puncture, in created in the dural membrane of a patient to gain access to anatomies therein. The dural membrane covers the inside of the cranium and the spinal canal, and forms an enclosed system that contains other membranes, the brain, spinal cord, and Cerebrospinal fluid (C.S.F.).
- After such procedures, it is often desirable to close the opening in the tissue. There are some known methods and devices for closing openings in tissue—each having advantages and disadvantages. There is an ongoing need to provide alternative designs, structures, assemblies, and/or treatment methods for closing an opening in the tissue of a patient, for example, the dural membrane of a patient.
- The invention provides several alternative designs, structures, assemblies, treatment methods and/or methods of manufacturing medical closure devices adapted and/or configured for closing an opening, for example, an incision or a puncture in the tissue of a patient, for example, the dural membrane of a patient.
- The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
-
FIG. 1 is a schematic cross sectional side view of a closure device in a first, unexpanded configuration; -
FIG. 2 is a schematic cross sectional side view of the closure device ofFIG. 1 , inserted into an opening in the dural membrane of an adult human being using an elongated insertion device; -
FIG. 3 is a schematic cross sectional side view of the closure device ofFIG. 2 , wherein the distal portion of the closure device is being engaged by the insertion device such that it is partially expanded; -
FIG. 4 is a schematic cross sectional side view of a the closure device ofFIG. 3 , wherein the distal portion of the closure device has been fully expanded to close the opening in the dural membrane; -
FIG. 5 is a schematic cross sectional side view of an alternative embodiment of a closure device in a first, unexpanded configuration; and -
FIG. 6 is a schematic cross sectional side view of the closure device ofFIG. 5 , wherein the distal portion of the closure device has been fully expanded to close the opening in the dural membrane. - While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
- For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
- All numeric values are herein assumed to be modified by the term “about,”whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
- Weight percent, percent by weight, wt %, wt-%, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the weight of the composition and multiplied by 100.
- The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
- As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
- The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention. For example, although shown and discussed with specific reference to some embodiments which are adapted for use in closing an opening, such as an incision or puncture, in the dural membrane in the body of a patient, it should be understood that the invention may be adapted or configured for use in other portions of the anatomy. For example, certain aspects of the invention may be applicable for use in closing an opening in any tissue that bounds a cavity in the anatomy of a patient. For example, certain aspects of the invention may be applicable for use in closing tissue such as other anatomical tissues or membranes or walls within the anatomy, for example, within the vasculature, abdominal (i.e. to close an incision made during a laparascopy or laparotomy) or other portions of the anatomy.
- An additional note with respect to the following description is that, while the closure device is described in terms of different sections, the device, or multiple sections thereof, may be made as a single element, for example, through extrusion, molding, casting, and the like. Variations in sizes and flexibility, as well as the inclusion of rigid or semi-rigid materials, should not be interpreted as requiring a certain method or type of construction. While the present description is written largely in terms of use in a human patient, the present invention may also be used with other organisms, for example in veterinary procedures by applying adaptations suited to a particular organism's anatomy.
- Refer now to
FIG. 1 , which is a diagrammatic cross sectional side view of one example embodiment of aclosure device 10 adapted and/or configured for closing an opening in tissue bounding a cavity in the anatomy of a patient. In this embodiment, thedevice 10 includes a body member, such as an elongatedtubular member 12 having adistal end 14 and aproximal end 16. Thetubular member 12 includes adistal section 18 anintermediate section 19, and aproximal section 20, and defines aninner lumen 22 extending there through. Thetubular member 12, and theinner lumen 22 defined thereby, extend generally along a longitudinal axis, X. In this document, the term “longitudinal” should be understood to mean in a direction corresponding to an elongated direction of theclosure device 10. Thetubular member 12 defines anouter surface 24 having an outer perimeter, and aninner surface 26 having an inner perimeter. Theouter surface 24 includes adistal portion 24 a corresponding to thedistal section 18, anintermediate portion 24 b corresponding to theintermediate section 19, and aproximal portion 24 c corresponding to theproximal section 20. Thedistal end 14 ofclosure device 10 may be angled or tapered, or may be generally flat, as shown or otherwise adapted to facilitate insertion. - Although shown as including a generally circular cross section,
tubular body member 12,proximal member 28, and thelumen 22, or portions of any of these, may include any of a broad variety of cross sectional shapes, often dependent upon the shape and size of the opening in the tissue to be closed or sealed, and/or upon the shape and size of other devices that may be used with theclosure device 10. The structure, or portions thereof, may include any of a broad variety of cross-sectional shapes, for example, circle, oval, square, rectangle, or other polygon or like shapes, or combinations thereof. Additionally, although thesections lumen 22 are shown as including generally constant outer and inner diameters along the length thereof, in other embodiments, these diameters may change or taper along the length of eachsegment lumen 22. - In this embodiment, the
device 10 also includes a firstnon-return valve 36 disposed in thelumen 22 atproximal end 16, and a secondnon-return valve 38 disposed in thelumen 22 at thedistal end 14. Thenon-return valves valves lumen 22 ofclosure device 10. For example, the non-return valve may be a hemostatic valve, membrane, or the like. In some embodiments, the non-return valves may be adapted and/or configured to include ports that can be accessed multiple times. - The
proximal section 20 includes aproximal portion 28 disposed adjacent theproximal end 16 of thetubular member 12. Theproximal portion 28 defines theouter surface portion 24 c that has an outer perimeter. Theintermediate section 19 of the tubular member definesouter surface portion 24 b that has an outer perimeter, and theouter surface portion 24 c has a greater outer perimeter than theouter surface portion 24 b. In other words, theproximal portion 28 is bigger around than theintermediate section 32. Additionally, in the embodiment shown, theproximal portion 28 defines adistal side surface 25 a and aproximal side surface 25 b. Thedistal side surface 25 a forms a stepped up orshoulder area 27 where theintermediate section 19 andproximal portion 28 meet. Theproximal portion 28 can be a separate member that is attached or connected to theouter surface 24 of the of thetubular member 12 at theproximal section 20, or can be a widening or expansion in unitary construction with thetubular member 12 to created the increased outer perimeter. As will be discussed in more detail below, in at least some embodiments, the widenedproximal portion 28 is adapted and/or configured such that theouter surface 24 c has an outer perimeter that is larger than an outer perimeter of the opening in the tissue of the patient that is to be closed. As such, in at least some embodiments, the widenedproximal portion 28 can be adapted and/or configured to acts as a stop and/or as a sealing portion that contacts the outer surface of the tissue in which the opening is being closed or sealed. - The
intermediate section 19 of thetubular member 12 extends distally of theproximal portion 28, and as indicated above, includes anouter surface portion 24 b that has an outer perimeter that is smaller than the outer perimeter of theproximal portion 28. Theintermediate section 19 can be a separate member that is attached or connected to theproximal section 20, or can be of unitary construction with theproximal section 20. As will be discussed in more detail below, in at least some embodiments, theintermediate section 19 can have anouter surface 32 that has an outer perimeter that is sized and/or configured for insertion into the opening in the tissue to be closed or sealed. It can also have a length that is sized and/or configured to extend within the opening to be closed or sealed, and in some embodiments, at least the entire length of the opening to be closed or sealed. Therefore, in at least some embodiments, theintermediate section 19 is adapted and/or configured to extend within the opening in the tissue to be closed or sealed between the widenedproximal portion 28 and thedistal section 18. - The
distal section 18 of thetubular member 12 extends distally of theintermediate section 19, and also includes anouter surface portion 24 c that has an outer perimeter. Thedistal section 18 can be a separate member that is attached or connected to theintermediate section 19, or can be of unitary construction with theintermediate section 19. Thedistal section 20 includes at least a portion thereof that is adapted and/or configured to be radially expandable from a first configuration, wherein theouter surface portion 24 c of thedistal section 18 is sized for insertion into and through the opening in the tissue to be closed, to a second, radially expanded configuration, wherein at least a portion of theouter surface portion 24 c of thedistal section 18 has a larger outer perimeter than when in the first configuration. As such, thedistal section 18 of thetubular member 12, when in the first, unexpanded configuration, is adapted and/or configured to be inserted through the opening in the tissue to be closed or sealed, and into the interior of the opening in the tissue. Thereafter, thedistal section 18 can be expanded into the second, expanded configuration, wherein it can be adapted and/or configured to act as a stop and/or as a sealing portion that contacts the inner surface of the tissue in which the opening is being closed or sealed. In the embodiment ofFIG. 1 , thedistal section 18 is shown in a first, or unexpanded configuration. - In some embodiments, the
distal section 18 is configured such that the radial expansion of at least a portion of the distal section can be achieved through the application of sufficient compressive longitudinal force to thedistal section 18. For example, in some embodiments, thedistal section 18 includes at least onearea 30 along the length thereof that has a reduced column strength relative to other portions of thedistal section 18. Some embodiments may include multiple areas of reduced column strength.Such areas 30 of reduced column strength are adapted to bend or fold in an outward direction relative to the longitudinal axis, such that theouter surface 24 a expands radially outward when a sufficient compressive longitudinal force is applied to thedistal section 18. In other words, thearea 30 has a weaker column strength than adjacent areas, and as such, it is adapted to give, and/or bend in an outward direction when thedistal section 18 is placed under sufficient compressive force. This giving and/or bending in an outward direction resulting in radial outward expansion of at least a portion of thedistal section 18 allows thedistal section 18 to transition from the unexpanded to the expanded configuration. - The
area 30 of reduced column strength can be achieved or created in any of a number of ways. For example, in the embodiment shown, theinner surface 26 of thedistal section 18 includes a cylindrical portion having a reduced wall thickness to create thearea 30 of reduced column strength. In other embodiments, an area of reduced column strength can be achieved through other means or mechanisms, for example, other structure, such as one or more groove, channel, furrow, notch, cut, fold, crease, wrinkle, ridge, kink, or other such structure defined in the wall of thedistal section 18 that may result in reduced column strength, or a propensity to fold outwardly under compressive force. Additionally, anarea 30 having reduced column strength or having a propensity to fold outwardly under compressive force may be created by using materials in such areas having different properties relative to the remainder of thedistal section 18. For example, such an area may be created by using a material having a different modulus of elasticity from the remaining portions of thedistal section 18. For example, such an area may include or be made of material having a reduced elastic modulus (i.e., increased flexibility) relative to other portions of thedistal section 18, and would therefore have reduced column strength, and/or have a propensity to fold outwardly under compressive force. - Some embodiments may also include a binding mechanism to help maintain the
distal section 18 in the expanded configuration. For example, in the embodiment shown, a bindingmaterial 32, such as an adhesive or other bonding agent or mechanism may be disposed on theinner surface 26 of thedistal section 18. The bindingmaterial 32 may be disposed on either side, or on both sided of thearea 30 such that when thearea 30 of reduced column strength bends or folds in an outward direction, adjacent portions of theinner surface 26 about the fold can be bound together to help maintain the expanded configuration. - Reference will now be made to
FIGS. 2-4 for description of one example or use and/or operation of the example embodiment shown inFIG. 1 .FIG. 2 is a diagrammatic side view of theclosure device 10 ofFIG. 1 , in the unexpanded first configuration, inserted into anopening 50 intissue 52 of a patient. For example, theopening 50 may be in thedural membrane 52 of a patient. Thedural membrane 52 forms an enclosed system that contains other membranes, the brain, spinal cord, and Cerebrospinal fluid (C.S.F.). Thedural membrane 52 is located beneathother tissue 54, and encloses and defines acavity 56, for example, the subarachnoid space of a patient. As shown, thedural membrane 52 includes anouter surface 53 and aninner surface 55. Some examples of procedures and devices that involve creating an opening in the dural membrane are disclosed copending U.S. patent application Ser. No.: 10/328,560 filed on Dec. 23, 2002, entitled METHODS AND APPARATUSES FOR NAVIGATING THE SUBARACHNOID SPACE; Ser. No. 09/905,670 filed on Jul. 13, 2001, entitled METHODS AND APPARATUSES FOR NAVIGATING THE SUBARACHNOID SPACE; Ser. No. 10/328,349 filed on Dec. 23, 2002, entitled INTRODUCER SHEATH; and Ser. No. 10/328,373, filed on Dec. 23, 2002, entitled GUIDE CATHETER FOR INTRODUCTION INTO THE SUBARACHNOID SPACE AND METHODS OF USE THEREOF, all of which are incorporated herein by reference. - The
closure device 10 is shown inserted through thetissue 54 above thedural membrane 52, and into theopening 50. Thedistal section 18 and theintermediate section 19 are sized to extend through or within theopening 50, while the widenedproximal portion 28 is adapted and/or configured such that theouter surface 24 c has an outer perimeter that is larger than an outer perimeter of theopening 50. Thedistal section 18 is shown in the unexpanded first configuration extending into thesubarachnoid space 56. Theintermediate section 19 is shown as extending within theopening 50. Theproximal section 20, includingproximal portion 28, is shown on the outside, or proximal side, of theopening 50. The distal side surface 25 a of the widenedproximal portion 28 makes contact with theouter surface 53 of thedural membrane 52 about theopening 50. - The
closure device 10 can be inserted into theopening 50 using any suitable device or mechanism. For example, an insertion device, such as aneedle 60, trochar, or the like, can be disposed into thelumen 22 of thedevice 10. Theneedle 60, or other device, can then be used to insert theclosure device 10 into theopening 50, and thedevice 10 can be advanced into theopening 50 until the widenedproximal portion 28 makes contact with theouter surface 53 of thedural membrane 52. In some embodiments, theneedle 60 may be inserted through both of thenon-return valves needle 60 such that insertion can be made with relatively little or no movement of thedevice 10 relative to theneedle 60. In some embodiments, theneedle 60 or other insertion device can be adapted or configured to include properties or structures that facilitate insertion and/or cooperation with thedevice 10. For example, some embodiments may include a tapered or sharpeneddistal tip 62 to facilitate insertion, orprotrusions 61 on the outer surface thereof that are adapted to create or provide additional frictional fit or engagement with thevalves - Although depicted as being inserted with a
needle 60, the device can be inserted into theopening 50 using any suitable insertion instrument, technique or apparatus. For example, in other examples, a guidewire, catheter, or the like, may be disposed such that it extends through theopening 50 in thedural membrane 52 and intosubarachnoid space 56, and may be used to guide or facilitate the introduction ofclosure device 10. - Refer now to
FIG. 3 , wherein thedistal section 18 is shown in a partially expanded configuration, in transition between the unexpanded configuration, and a fully expanded configuration. Once thedevice 10 is inserted into theopening 50, as shown inFIG. 2 , theneedle 60 can begin to be withdrawn, as shown inFIG. 3 , for example, along longitudinal axis X. In some embodiments, it may be necessary during withdrawal of theneedle 60 to apply pressure to the widenedproximal portion 28 such that it maintains a desired position, for example, in contact with theouter surface 53 of thedural membrane 52 about theopening 50. - During withdrawal of the
needle 60, theneedle 60 can engage structure in thedistal section 18 of thetubular member 12. For example, in the embodiment shown, theneedle 60, through friction, engages the distalnon-return valve 38. Theprotrusions 61 on theneedle 60 can aid in the frictional engagement of the distalnon-return valve 38, or may in some embodiments provide for an interference fit with the distalnon-return valve 38. As theneedle 60 is withdrawn, a compressive longitudinal force is applied to the walls of thetubular member 12 due to the frictional or interference engagement of theneedle 60 with the distalnon-return valve 38. The compressive longitudinal force is sufficient to cause theareas 30 of reduced column strength on thedistal section 18 to bend or fold in an outward direction relative to the longitudinal axis X. As the bend or fold is created, theouter surface 24 a expands radially outward. In the embodiment shown inFIG. 3 , the longitudinal force and the bending and/or folding of thedistal section 18 about thearea 30 creates a proximal region or fold 65 in thedistal section 18 that is pulled toward theinner surface 55 of thedural membrane 52. Additionally, a distal region or fold 63 in thedistal section 18 is created, and thedistal region 63 is pulled toward theproximal region 65. - Refer now to
FIG. 4 , wherein thedistal section 18 is shown in a fully expanded configuration. In this fully expanded configuration, at least a portion of the proximal region or fold 65 in thedistal section 18 is pulled against theinner surface 55 of thedural membrane 52. Additionally, the distal region or fold 63 is pulled toward theproximal region 65, and theadhesive material 32 can act to bind the tworegions outer surface 24 a of the distal region has expanded radially outward such that it has an outer perimeter that is greater than the outer perimeter of theopening 50 in thedural membrane 52. As such, theopening 50 has been closed by theclosure device 10. The closure device is maintained in position by the radially expanded distal section engaging theinner surface 55 of the dural membrane, and the widenedproximal portion 28 engaging theouter surface 53 of thedural membrane 52 about theopening 50. Theintermediate section 19 extends through the opening, and interconnects thedistal section 18 and theproximal portion 28. When in place, and the distal section is in the expanded configuration, theclosure device 10 acts to at least substantially close or seal theopening 50. - In some other embodiments, it is also contemplated that a binding mechanism, such as an adhesive type material, may b e used on the
outer surface 24 a of thedistal section 18. For example, an adhesive material could be included on the outer surface of theproximal region 65 of thedistal section 18. At least a portion of the outer surface of thisregion 65 may come into contact with theinner surface 55 of the dural membrane, and an adhesive material applied thereto could provide for a bond between theproximal region 65 and theinner surface 55 of the dural membrane. Such a bond may help maintain theclosure device 10 in the expanded configuration, and may additionally help to seal the opening. Additionally, in some embodiments, a binding mechanism, such as an adhesive type material, may be used on an outer surface of theproximal portion 28. For example, an adhesive material may be applied to the distal side surface 25 a and could provide for a bond between theproximal portion 28 and theouter surface 53 of the dural membrane. Such a bond may help maintain theclosure device 10 in position relative to the opening, and may additionally help to seal theopening 50. It is contemplated that in at least some such embodiments, the adhesive material used would be compatible with the tissue or anatomy in which it is being used. - Additionally, in some embodiments, when the
closure device 10 is in place within the anatomy, it can be used as a port for introduction of other devices and/or structures. For example, with theclosure device 10 in place, in some embodiments, additional structures may be introduced into the cavity defined by the tissue, (such as the subarachnoid space in the case of the dural membrane), through thelumen 22 within theclosure device 10. For example, a guidewire, catheter, introducer sheath, needle, trochar, endoscopes, flush tubes, and other devices, or the like, may be advanced through thelumen 22 via thevalves cavity 56. Such additional devices may then be navigated or advanced within thecavity 56, or may take samples of fluid, such as CSF, or may introduce material, such as drugs, marker fluid, or the like, into thecavity 56. Theclosure device 10, including for example thenon-return valves single lumen 22, other embodiments may include multiple lumens. Such an embodiment can be, for example, adapted for use with or introduction of multiple devices, such as guidewires, catheters and the like, through the separate lumens. - Additionally, the
closure device 10 may act as a platform for additional structures or devices. For example, thedistal section 18 may include a transducer, for example, a microsensor embedded into a wall of theclosure device 10 for sensing the temperature, pressure, body chemistry or the like inside thecavity 56, such as the subarachnoid space, or other anatomy in which thedevice 10 is used. Such a transducer may be coupled to an electric (i.e. a wire) or optic connection running along, through, or embedded into thetubular member 12 from a distal location to a proximal location. In other embodiments, such a transducer may be a wireless sensor, for example, a wireless resonant pressure or temperature sensor. The transducer may be included for determining a physiologic property during an operation, or to assist in diagnosis. Any of a wide variety of small sensing devices may be used as a transducer including, for example, resonant sensors, micromachined sensors, or even more conventional sensors which, though relatively bulky, may be incorporated into or attached to theclosure device 10. - The size and dimensions of the
closure device 10, and/or components or segments thereof, is greatly dependent upon the size and dimensions of the particular anatomy in which it is intended for use, and the size of the opening in the anatomy that is being closed. Thus, the lengths and diameters of different segments of theclosure device 10 may thus be adapted for particular usages, and can vary greatly. For example, the outer diameter and length of theintermediate section 19 and thedistal section 18 in the unexpanded configuration may be adapted for entry into a particular opening size in a particular anatomy, as the allowed outer diameters and length available and necessary for entry may vary from one particular opening size and anatomy to the next, as well as from one patient to the next. Likewise, the length and outer diameter of the proximal section, including theproximal portion 28, and thedistal section 18 in an expanded configuration may also vary greatly, depending upon the size of the opening to be closed, and the available space in the anatomy. In some example embodiments, the device can have dimensions that are particularly adapted and/or configured for closing an opening in the dural membrane. Additionally, the dimensions of thelumen 22 and of thenon-return valves - With respect to the
proximal section 20, it is possible to have an evenlarger lumen 22 within that section to make the lumen more easily accessed and/or passed. For example, because theproximal section 20 is not inserted into theopening 50 the outer diameter of theproximal section 20 is not as subject to the anatomical limits of a patient into whom the device is inserted, and hence there are fewer limits on theinner lumen 22 diameter in theproximal section 20, either. - A wide variety of materials may be used to make the
closure device 10, or sections or portions thereof. For example, theclosure device 10, including thetubular body member 12, theproximal member 28, or portions thereof, can be manufactured from any suitable material to impart the desired characteristics. Some examples of suitable materials can include, for example, polymers, metal-polymer composites, metals, metal alloys, or the like, or combinations or mixtures thereof. Examples of some suitable materials include, but are not limited to, polymers such as polyoxymethylene, polybutylene terephthalate, polyether block ester, polyether block amide, fluorinated ethylene propylene, polyethylene, polypropylene, polyvinylchloride, polyurethane, polytetrafluoroethylene (PTFE), polyether-ether ketone, polyimide, polyamide, polyphenylene sulfide, polyphenylene oxide, polysufone, nylon, perfluoro(propyl vinyl ether), polyether-ester, polymer/metal composites, etc., or mixtures, blends or combinations thereof. One example of a suitable polyether block ester is available under the trade name ARNITEL, and one suitable example of a polyether block amide is available under the trade name PEBAX®, from ATOMCHEM POLYMERS, Birdsboro, Pa. In some embodiments, the polymer material of certain sections of theclosure device 10 can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 5% LCP. This has been found to enhance torqueability in some embodiments. - Some examples of suitable metals and metal alloys include nickel-titanium alloy, such as linear elastic or superelastic nitinol, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, stainless steel, such as 304 v stainless steel; or the like; or other suitable material.
- The
closure device 10, for example thetubular body member 12 and theproximal member 28, can be made of unitary construction, or can be made up of a plurality of tubular segments coupled together, each segment being made of materials having the same or different properties. For example, in some embodiments, different portions or sections of thedevice 10 can include or be made of materials, or have structure that renders them more flexible or softer than other portions of thedevice 10. For example, in some embodiments, thedistal section 18 may be more flexible or softer than at least a part of the intermediate orproximal sections distal section 18 can be less flexible or harder than at least a part of the of the intermediate orproximal sections - It can be appreciated that the
closure device 10 can be made of a single layer of material, or a plurality of layers. For example, thetubular body member 12 and theproximal member 28, can include one or more layers disposed or stacked on top of one another. The different layers may be made of the same material or different materials. In one example, one of the layers may be made of a generally less flexible polymer than the other(s). In another example, one or more of the layers may be made of or doped with an indicator material to enhance imaging. Additionally, in some embodiments, one of the layers may act as a support layer, and can include, for example, support structure, such as a braid, coil, or other such structures. Theclosure device 10, including thetubular body member 12 and theproximal member 28 can be constructed using any appropriate technique, for example, by extrusion, a heat bonding process, casting, molding, and the like. - In some embodiments, the
device 10 may be provided with an initial rigid shape, but may be re-shaped by a physician before insertion to better match the anatomy of the patient. For example, thedistal section 18,intermediate section 19, and/orproximal section 20, or portions thereof, may be made of a material such as PTFE that is rigid, but may be heated and re-shaped, so that once re-cooled, the distal section,intermediate section 18, and/orproximal section 20 will retain the new shape. - In some embodiments, the closure device, or portions thereof can be made of or include a lubricious material, for example tetrafluoroethylene, or a copolymer of tetrafluoroethylene with perfluoroalkyl vinyl ether (more specifically, perfluoropropyl vinyl ether or perfluoromethyl vinyl ether), or the like. Also, in some embodiments, the closure device, or sections or portions thereof can include a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of the
device 10, or within thelumen 22 of the device. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which can improve insertion, and when disposed in thelumen 22, and improve insertions of other devices therethrough. Lubricious coatings can also aid in this manner. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference. - The distal section 18 (as well as the rest of
closure device 10, as desired) may also include one or more markers or a coating to enhance its imaging visibility, for example MRI visibility, and, for some embodiments, may include radiopaque materials or other high visibility materials adapted for use with other imaging technologies, such as fluoroscopy. For some embodiments suggested herein, the closure device may be made of material and structure compatible with certain imaging techniques, for example an MRI scanning compatible material or structure. For example, ferrous materials, such as some stainless steel alloys often used to provide braided reinforcement to catheters, are typically magnetically responsive, and are generally not used in conjunction with MRI equipment, or are provided with structure that would render them compatible with MRI equipment. However, other embodiments, may not include materials that are currently MRI compatible. - Refer now to
FIG. 5 which is a side view of another illustrative embodiment showing a closure device 110, this time including some alterations to the tubular member 112. In this embodiment, the device 110 also includes a body member, such as an elongated tubular member 112 having adistal end 114 and aproximal end 116. The tubular member 112 includes a distal section 118 anintermediate section 119, and aproximal section 120, and defines aninner lumen 122 extending there through. The tubular member 112, and theinner lumen 122 defined thereby, extend generally along a longitudinal axis, X. Likewise, the tubular member 112 defines anouter surface 124 having an outer perimeter, and an inner surface 126 having an inner perimeter. Theouter surface 124 includes adistal portion 124 a corresponding to the distal section 118, anintermediate portion 124 b corresponding to theintermediate section 119, and aproximal portion 124 c corresponding to theproximal section 120. Similar to the embodiment discussed above, the device 110 also includes a firstnon-return valve 136 disposed in thelumen 122 atproximal end 116, and a secondnon-return valve 138 disposed in thelumen 122 at thedistal end 114. - The
proximal section 120 andintermediate section 119 are configured substantially similar to theproximal section 20 andintermediate section 19 embodiment shown inFIG. 1-4 . For example, theproximal section 120 includes aproximal portion 128 defining theouter surface portion 24 c that has an outer perimeter that is greater than the outer perimeter ofouter surface portion 24 b. Additionally, theproximal portion 128 defines adistal side surface 125 a and aproximal side surface 125 b, and a stepped up or shoulder area 127. - However, the distal segment 118 in this embodiment includes a plurality of
areas 130 along the length thereof that have a reduced column strength relative to other portions of the distal section 118.Such areas 130 of reduced column strength are adapted to bend or fold in an outward direction relative to the longitudinal axis, such that theouter surface 124 a expands radially outward when a sufficient compressive longitudinal force is applied to the distal section 118. This giving and/or bending in an outward direction resulting in radial outward expansion of at least a portion of the distal section 118 allows the distal section 118 to transition from an unexpanded to an expanded configuration. In this embodiment, theareas 130 of reduced column strength are created by reducing the wall thickness on a portion of the inner surface 126 of the distal section 118. - In
FIG. 5 , the closure device 110 has been inserted into anopening 50 intissue 52 of a patient, for example, anopening 50 in thedural membrane 52 of a patient. Aneedle 60 was used for insertion, and theneedle 60 is being withdrawn, such that the distal section 118 is in a partially expanded configuration. During withdrawal, theneedle 60, engages the distalnon-return valve 138, and a compressive longitudinal force is applied to the walls of the tubular member 112. The compressive longitudinal force is sufficient to cause theareas 130 of reduced column strength to bend or fold in an outward direction relative to the longitudinal axis X. As the bends or folds are created, theouter surface 24 a expands radially outward. In the embodiment shown inFIG. 5 , the longitudinal force and the bending and/or folding of the distal section 118 about theareas 30 creates a plurality offolds 165, eachfold 165 being proximal to anadjacent area 130. Thefolds 165 are pulled in a proximal direction. The proximal—most fold 165 is pulled toward theinner surface 55 of thedural membrane 52. Additionally, the longitudinal force creates a plurality offolds 163, eachfold 163 being distal to anadjacent area 130. Each of thefolds 163 is pulled toward the associatedproximal fold 165 about theareas 130. - Refer now to
FIG. 6 , wherein the distal section 118 is shown in a fully expanded configuration. In this fully expanded configuration, at least a portion of the mostproximal fold 165 is pulled against theinner surface 55 of thedural membrane 52. Additionally, each of thefolds 163 is pulled toward the associated folds 165 about each of theareas 130. Anadhesive material 132 can act to bind each of the twofolds outer surface 124 a of the distal region 118 has expanded radially outward such that it has an outer perimeter that is greater than the outer perimeter of theopening 50 in thedural membrane 52. As such, theopening 50 has been closed by the closure device 110. The closure device is maintained in position by the radially expanded distal section 118 engaging theinner surface 55 of the dural membrane, and the widenedproximal portion 128 engaging theouter surface 53 of thedural membrane 52 about theopening 50. Theintermediate section 119 extends through theopening 50, and interconnects the distal section 118 and theproximal portion 128. When in place, and the distal section 118 is in the expanded configuration, the closure device 110 acts to at least substantially close or seal theopening 50. - The present invention should not be considered limited to the particular examples described above, but rather should be understood to cover all aspects of the invention as fairly set out in the attached claims. For example, as discussed above, it should be understood that other embodiments of such devices can be adapted and/or configured for use in portions of the anatomy other than the dural membrane to close or seal an opening in other tissue. Various modifications, equivalent processes, as well as numerous structures to which the present invention may be applicable will be readily apparent to those of skill in the art to which the present invention is directed upon review of the instant specification. It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The scope of the invention is, of course, defined in the language in which the appended claims are expressed.
Claims (40)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/636,791 US20050049634A1 (en) | 2003-08-07 | 2003-08-07 | Medical closure device |
PCT/US2004/025282 WO2005013832A1 (en) | 2003-08-07 | 2004-08-05 | Medical closure device |
US11/960,641 US8292917B2 (en) | 2003-08-07 | 2007-12-19 | Medical closure device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/636,791 US20050049634A1 (en) | 2003-08-07 | 2003-08-07 | Medical closure device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/960,641 Continuation US8292917B2 (en) | 2003-08-07 | 2007-12-19 | Medical closure device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050049634A1 true US20050049634A1 (en) | 2005-03-03 |
Family
ID=34135587
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/636,791 Abandoned US20050049634A1 (en) | 2003-08-07 | 2003-08-07 | Medical closure device |
US11/960,641 Expired - Fee Related US8292917B2 (en) | 2003-08-07 | 2007-12-19 | Medical closure device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/960,641 Expired - Fee Related US8292917B2 (en) | 2003-08-07 | 2007-12-19 | Medical closure device |
Country Status (2)
Country | Link |
---|---|
US (2) | US20050049634A1 (en) |
WO (1) | WO2005013832A1 (en) |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050096633A1 (en) * | 2003-10-31 | 2005-05-05 | Ari Moskowitz | Apparatus and method for catheterizing the dura of a patient using a dural patch |
US20050267520A1 (en) * | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US20060161159A1 (en) * | 1999-02-02 | 2006-07-20 | Dreyfuss Peter J | PEEK ribbed suture anchor |
US20060212063A1 (en) * | 2005-03-18 | 2006-09-21 | Wilk Patent, Llc | Surgical device and associated trans-organ surgical method |
US20070010857A1 (en) * | 2005-07-05 | 2007-01-11 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US20070078302A1 (en) * | 2005-08-05 | 2007-04-05 | Ortiz Mark S | Method and apparatus for sealing a gastric opening |
US20070106246A1 (en) * | 2005-05-12 | 2007-05-10 | Modesitt D B | Access and closure device and method |
US20070203517A1 (en) * | 2005-09-27 | 2007-08-30 | Williams Michael S | Transgastric surgical devices and procedures |
US20080228198A1 (en) * | 2007-03-13 | 2008-09-18 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US20080281212A1 (en) * | 2007-03-15 | 2008-11-13 | Nunez Anthony I | Transseptal monitoring device |
US20090105744A1 (en) * | 2007-10-17 | 2009-04-23 | Modesitt D Bruce | Methods for forming tracts in tissue |
US20090221915A1 (en) * | 2008-03-03 | 2009-09-03 | Ethicon Endo-Surgery, Inc. | Transluminal tissue markers |
WO2009117435A2 (en) * | 2008-03-17 | 2009-09-24 | Northwestern University | Devices and methods for percutaneous access, hemostasis, and closure |
EP2117423A2 (en) * | 2007-01-26 | 2009-11-18 | Endotronix, Inc. | Vascular closure device having sensor |
US20090287229A1 (en) * | 2008-05-19 | 2009-11-19 | Ams Research Corporation | Collapsible Tissue Anchor Device and Method |
US20100016786A1 (en) * | 2008-07-21 | 2010-01-21 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
US20100016810A1 (en) * | 2008-07-21 | 2010-01-21 | Arstasis. Inc., | Devices and methods for forming tracts in tissue |
US20100030259A1 (en) * | 2007-02-01 | 2010-02-04 | Dusan Pavcnik | Closure Device and Method of Closing a Bodily Opening |
US7678133B2 (en) | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
US20100100107A1 (en) * | 2008-10-20 | 2010-04-22 | IMDS, Inc. | Systems and methods for cerebrospinal fluid repair |
US20100308974A1 (en) * | 2007-03-15 | 2010-12-09 | Rowland Harry D | Wireless sensor reader |
US20110125178A1 (en) * | 2009-05-15 | 2011-05-26 | Michael Drews | Devices, methods and kits for forming tracts in tissue |
US20110208215A1 (en) * | 2009-09-22 | 2011-08-25 | Modesitt D Bruce | Devices, methods, and kits for forming tracts in tissue |
US20120022562A1 (en) * | 2010-07-23 | 2012-01-26 | Boston Scientific Scimed, Inc. | Device to detect internal bleeding |
US20120035644A1 (en) * | 2010-08-03 | 2012-02-09 | Eskaros Sherif A | Tissue Plug |
US8154389B2 (en) | 2007-03-15 | 2012-04-10 | Endotronix, Inc. | Wireless sensor reader |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
US20140222065A1 (en) * | 2013-02-01 | 2014-08-07 | St. Jude Medical Puerto Rico Llc | Hemostasis devices, components for hemostasis devices, and related methods |
US8894582B2 (en) | 2007-01-26 | 2014-11-25 | Endotronix, Inc. | Cardiac pressure monitoring device |
US8945211B2 (en) | 2008-09-12 | 2015-02-03 | Mitralign, Inc. | Tissue plication device and method for its use |
US9023074B2 (en) | 2010-10-15 | 2015-05-05 | Cook Medical Technologies Llc | Multi-stage occlusion devices |
US9358111B2 (en) | 2007-03-13 | 2016-06-07 | Mitralign, Inc. | Tissue anchors, systems and methods, and devices |
US9489831B2 (en) | 2007-03-15 | 2016-11-08 | Endotronix, Inc. | Wireless sensor reader |
US9996712B2 (en) | 2015-09-02 | 2018-06-12 | Endotronix, Inc. | Self test device and method for wireless sensor reader |
US10003862B2 (en) | 2007-03-15 | 2018-06-19 | Endotronix, Inc. | Wireless sensor reader |
US10154835B2 (en) | 2013-05-09 | 2018-12-18 | Essential Medical, Inc. | Vascular closure device with conforming plug member |
US10206592B2 (en) | 2012-09-14 | 2019-02-19 | Endotronix, Inc. | Pressure sensor, anchor, delivery system and method |
CN109464172A (en) * | 2018-12-05 | 2019-03-15 | 江研伟 | Dura mater closed system and its application method under a kind of scope |
US10430624B2 (en) | 2017-02-24 | 2019-10-01 | Endotronix, Inc. | Wireless sensor reader assembly |
US10441753B2 (en) | 2012-05-25 | 2019-10-15 | Arstasis, Inc. | Vascular access configuration |
US10675447B2 (en) | 2012-05-25 | 2020-06-09 | Arstasis, Inc. | Vascular access configuration |
US10814980B2 (en) | 2017-09-02 | 2020-10-27 | Precision Drone Services Intellectual Property, Llc | Distribution assembly for an aerial vehicle |
US10918373B2 (en) | 2013-08-31 | 2021-02-16 | Edwards Lifesciences Corporation | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US11103146B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Wireless sensor for measuring pressure |
EP4014843A1 (en) * | 2020-12-16 | 2022-06-22 | HoliStick Medical | Medical implant and method of measuring a parameter |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US11615257B2 (en) | 2017-02-24 | 2023-03-28 | Endotronix, Inc. | Method for communicating with implant devices |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
US7983734B2 (en) | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US20090030309A1 (en) | 2007-07-26 | 2009-01-29 | Senorx, Inc. | Deployment of polysaccharide markers |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US7651505B2 (en) | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US6575991B1 (en) | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
ES2409758T3 (en) | 2000-11-20 | 2013-06-27 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
CN1705462A (en) | 2002-10-21 | 2005-12-07 | 米特拉利根公司 | Method and apparatus for performing catheter-based annuloplasty using local plications |
US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
US7431726B2 (en) | 2003-12-23 | 2008-10-07 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
CA2562580C (en) | 2005-10-07 | 2014-04-29 | Inrad, Inc. | Drug-eluting tissue marker |
US7798998B2 (en) | 2006-10-06 | 2010-09-21 | Surgiquest, Inc. | Elastically deformable surgical access device |
US7806870B2 (en) | 2006-10-06 | 2010-10-05 | Surgiquest, Incorporated | Elastically deformable surgical access device having telescoping guide tube |
US8795235B2 (en) | 2006-10-06 | 2014-08-05 | Surgiquest, Inc. | Devices for and methods of performing minimally-invasive surgical procedures through a single incision |
ES2443526T3 (en) | 2006-10-23 | 2014-02-19 | C.R. Bard, Inc. | Breast marker |
US8326401B2 (en) | 2006-11-24 | 2012-12-04 | Senorx, Inc. | MRI detectable obturator |
EP2097022B1 (en) | 2006-11-24 | 2014-07-23 | Senorx, Inc. | Mri detectable obturator |
US20080125766A1 (en) * | 2006-11-24 | 2008-05-29 | Senorx, Inc. | MRI imageable assembly |
EP3542748B1 (en) | 2006-12-12 | 2023-08-16 | C. R. Bard, Inc. | Multiple imaging mode tissue marker |
US8401622B2 (en) | 2006-12-18 | 2013-03-19 | C. R. Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
US8311610B2 (en) | 2008-01-31 | 2012-11-13 | C. R. Bard, Inc. | Biopsy tissue marker |
US9192362B2 (en) | 2008-08-18 | 2015-11-24 | Cook Medical Technologies Llc | Device and method for closure of vessel access site |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
CA2742765C (en) | 2008-12-30 | 2016-04-12 | C.R. Bard Inc. | Marker delivery device for tissue marker placement |
US8814903B2 (en) * | 2009-07-24 | 2014-08-26 | Depuy Mitek, Llc | Methods and devices for repairing meniscal tissue |
US8828053B2 (en) | 2009-07-24 | 2014-09-09 | Depuy Mitek, Llc | Methods and devices for repairing and anchoring damaged tissue |
US9603588B2 (en) | 2009-08-31 | 2017-03-28 | St. Jude Medical Puerto Rico Llc | Compressible arteriotomy locator for vascular closure devices and methods |
US8500776B2 (en) * | 2010-02-08 | 2013-08-06 | Covidien Lp | Vacuum patch for rapid wound closure |
US9743919B2 (en) | 2010-04-27 | 2017-08-29 | DePuy Synthes Products, Inc. | Stitch lock for attaching two or more structures |
US9451938B2 (en) | 2010-04-27 | 2016-09-27 | DePuy Synthes Products, Inc. | Insertion instrument for anchor assembly |
BR112012027242A2 (en) | 2010-04-27 | 2017-07-18 | Synthes Gmbh | mounting bracket including an expandable anchor |
US9597064B2 (en) | 2010-04-27 | 2017-03-21 | DePuy Synthes Products, Inc. | Methods for approximating a tissue defect using an anchor assembly |
US9307977B2 (en) | 2010-11-04 | 2016-04-12 | Conmed Corporation | Method and apparatus for securing an object to bone, including the provision and use of a novel suture assembly for securing suture to bone |
US9307978B2 (en) | 2010-11-04 | 2016-04-12 | Linvatec Corporation | Method and apparatus for securing an object to bone, including the provision and use of a novel suture assembly for securing an object to bone |
AU2012217577B2 (en) | 2011-02-16 | 2016-06-09 | Linvatec Corporation | Method and apparatus for securing an object to bone |
CN104000627B (en) * | 2013-02-26 | 2017-04-12 | 米特拉利根公司 | tissue anchor and anchoring system |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
US10368909B2 (en) | 2015-02-26 | 2019-08-06 | Titan Medical Inc. | Apparatus for providing access for a surgical procedure |
EP3366224A1 (en) * | 2017-02-23 | 2018-08-29 | Berlin Heart GmbH | Closure device for an opening in the heart of a patient |
US10363064B2 (en) | 2017-08-29 | 2019-07-30 | Titan Medical Inc. | Apparatus for providing access to a body cavity of a living animal for a medical procedure |
EP4117537A4 (en) * | 2020-03-12 | 2023-08-09 | Deinde Medical Corp. | Implantable closure device to seal punctures of spinal cord and brain meninges membranes and prevent leakage of cerebrospinal fluid |
Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US5053046A (en) * | 1988-08-22 | 1991-10-01 | Woodrow W. Janese | Dural sealing needle and method of use |
US5254133A (en) * | 1991-04-24 | 1993-10-19 | Seid Arnold S | Surgical implantation device and related method of use |
US5370660A (en) * | 1993-11-01 | 1994-12-06 | Cordis Corporation | Apparatus and method for delivering a vessel plug into the body of a patient |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5441517A (en) * | 1991-11-08 | 1995-08-15 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5476469A (en) * | 1992-10-19 | 1995-12-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5507755A (en) * | 1993-08-03 | 1996-04-16 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5531759A (en) * | 1994-04-29 | 1996-07-02 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5540715A (en) * | 1992-07-16 | 1996-07-30 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5545178A (en) * | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5601602A (en) * | 1990-10-01 | 1997-02-11 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5634944A (en) * | 1995-02-23 | 1997-06-03 | The Nemours Foundation | Body membrane prosthesis |
US5643317A (en) * | 1992-11-25 | 1997-07-01 | William Cook Europe S.A. | Closure prosthesis for transcatheter placement |
US5772609A (en) * | 1993-05-11 | 1998-06-30 | Target Therapeutics, Inc. | Guidewire with variable flexibility due to polymeric coatings |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5810884A (en) * | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US5830232A (en) * | 1997-04-14 | 1998-11-03 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5910155A (en) * | 1998-06-05 | 1999-06-08 | United States Surgical Corporation | Vascular wound closure system |
US5984948A (en) * | 1997-04-14 | 1999-11-16 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US6004341A (en) * | 1996-12-05 | 1999-12-21 | Loma Linda University Medical Center | Vascular wound closure device |
US6203554B1 (en) * | 1999-11-23 | 2001-03-20 | William Roberts | Apparatus, kit and methods for puncture site closure |
US6221056B1 (en) * | 1996-12-20 | 2001-04-24 | David G. Silverman | Strong diaphragm/safe needle units and components for transfer of fluids |
US6283984B1 (en) * | 1997-05-08 | 2001-09-04 | Tegementa, Llc | Dural closing surgical forceps |
US6312446B1 (en) * | 1996-03-22 | 2001-11-06 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US6315787B1 (en) * | 1998-11-24 | 2001-11-13 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
US6334865B1 (en) * | 1998-08-04 | 2002-01-01 | Fusion Medical Technologies, Inc. | Percutaneous tissue track closure assembly and method |
US6482235B1 (en) * | 1999-08-18 | 2002-11-19 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
US20030014016A1 (en) * | 2001-07-13 | 2003-01-16 | Purdy Phillip D. | Methods and apparatuses for navigating the subaracnhnoid space |
US6531147B2 (en) * | 1996-03-22 | 2003-03-11 | Focal, Inc. | Compliant tissue sealants |
US20030093105A1 (en) * | 2001-07-13 | 2003-05-15 | Scimed Life Systems, Inc. | Guide catheter for introduction into the subarachnoid space and methods of use thereof |
US20030097082A1 (en) * | 2001-07-13 | 2003-05-22 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
US20030130577A1 (en) * | 2001-07-13 | 2003-07-10 | Board Of Regents, The University Of Texas System | Introducer sheath |
US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6139510A (en) | 1994-05-11 | 2000-10-31 | Target Therapeutics Inc. | Super elastic alloy guidewire |
US20030191496A1 (en) * | 1997-03-12 | 2003-10-09 | Neomend, Inc. | Vascular sealing device with microwave antenna |
FR2810555B1 (en) * | 2000-06-26 | 2003-05-30 | Soprane Sa | REUSABLE CATHETER |
IL139086A0 (en) * | 2000-10-17 | 2001-11-25 | Vasculab Ltd | Device and method for sealing a puncture in a blood vessel |
-
2003
- 2003-08-07 US US10/636,791 patent/US20050049634A1/en not_active Abandoned
-
2004
- 2004-08-05 WO PCT/US2004/025282 patent/WO2005013832A1/en active Application Filing
-
2007
- 2007-12-19 US US11/960,641 patent/US8292917B2/en not_active Expired - Fee Related
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US5053046A (en) * | 1988-08-22 | 1991-10-01 | Woodrow W. Janese | Dural sealing needle and method of use |
US5601602A (en) * | 1990-10-01 | 1997-02-11 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5254133A (en) * | 1991-04-24 | 1993-10-19 | Seid Arnold S | Surgical implantation device and related method of use |
US5441517A (en) * | 1991-11-08 | 1995-08-15 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5540715A (en) * | 1992-07-16 | 1996-07-30 | Sherwood Medical Company | Device for sealing hemostatic incisions |
US5476469A (en) * | 1992-10-19 | 1995-12-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5643317A (en) * | 1992-11-25 | 1997-07-01 | William Cook Europe S.A. | Closure prosthesis for transcatheter placement |
US5772609A (en) * | 1993-05-11 | 1998-06-30 | Target Therapeutics, Inc. | Guidewire with variable flexibility due to polymeric coatings |
US5383896A (en) * | 1993-05-25 | 1995-01-24 | Gershony; Gary | Vascular sealing device |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5507755A (en) * | 1993-08-03 | 1996-04-16 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5370660A (en) * | 1993-11-01 | 1994-12-06 | Cordis Corporation | Apparatus and method for delivering a vessel plug into the body of a patient |
US5545178A (en) * | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5531759A (en) * | 1994-04-29 | 1996-07-02 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5634944A (en) * | 1995-02-23 | 1997-06-03 | The Nemours Foundation | Body membrane prosthesis |
US6531147B2 (en) * | 1996-03-22 | 2003-03-11 | Focal, Inc. | Compliant tissue sealants |
US6312446B1 (en) * | 1996-03-22 | 2001-11-06 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US5810884A (en) * | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US6004341A (en) * | 1996-12-05 | 1999-12-21 | Loma Linda University Medical Center | Vascular wound closure device |
US6221056B1 (en) * | 1996-12-20 | 2001-04-24 | David G. Silverman | Strong diaphragm/safe needle units and components for transfer of fluids |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5830232A (en) * | 1997-04-14 | 1998-11-03 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US5984948A (en) * | 1997-04-14 | 1999-11-16 | Hasson; Harrith M. | Device for closing an opening in tissue and method of closing a tissue opening using the device |
US6283984B1 (en) * | 1997-05-08 | 2001-09-04 | Tegementa, Llc | Dural closing surgical forceps |
US5910155A (en) * | 1998-06-05 | 1999-06-08 | United States Surgical Corporation | Vascular wound closure system |
US6334865B1 (en) * | 1998-08-04 | 2002-01-01 | Fusion Medical Technologies, Inc. | Percutaneous tissue track closure assembly and method |
US6315787B1 (en) * | 1998-11-24 | 2001-11-13 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
US6482235B1 (en) * | 1999-08-18 | 2002-11-19 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
US6203554B1 (en) * | 1999-11-23 | 2001-03-20 | William Roberts | Apparatus, kit and methods for puncture site closure |
US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
US20030014016A1 (en) * | 2001-07-13 | 2003-01-16 | Purdy Phillip D. | Methods and apparatuses for navigating the subaracnhnoid space |
US20030093105A1 (en) * | 2001-07-13 | 2003-05-15 | Scimed Life Systems, Inc. | Guide catheter for introduction into the subarachnoid space and methods of use thereof |
US20030097082A1 (en) * | 2001-07-13 | 2003-05-22 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
US20030130577A1 (en) * | 2001-07-13 | 2003-07-10 | Board Of Regents, The University Of Texas System | Introducer sheath |
Cited By (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060161159A1 (en) * | 1999-02-02 | 2006-07-20 | Dreyfuss Peter J | PEEK ribbed suture anchor |
US20050096633A1 (en) * | 2003-10-31 | 2005-05-05 | Ari Moskowitz | Apparatus and method for catheterizing the dura of a patient using a dural patch |
US7998169B2 (en) | 2004-05-12 | 2011-08-16 | Arstasis, Inc. | Access and closure device and method |
US8002793B2 (en) | 2004-05-12 | 2011-08-23 | Arstasis, Inc. | Access and closure device and method |
US8012168B2 (en) | 2004-05-12 | 2011-09-06 | Arstasis, Inc. | Access and closure device and method |
US20070032802A1 (en) * | 2004-05-12 | 2007-02-08 | Modesitt D B | Access and closure device and method |
US8002791B2 (en) | 2004-05-12 | 2011-08-23 | Arstasis, Inc. | Access and closure device and method |
US20050267520A1 (en) * | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US8002792B2 (en) | 2004-05-12 | 2011-08-23 | Arstasis, Inc. | Access and closure device and method |
US7678133B2 (en) | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
US20060212063A1 (en) * | 2005-03-18 | 2006-09-21 | Wilk Patent, Llc | Surgical device and associated trans-organ surgical method |
US20070255313A1 (en) * | 2005-05-12 | 2007-11-01 | Arstasis, Inc. | Access and closure device and method |
US8002794B2 (en) | 2005-05-12 | 2011-08-23 | Arstasis, Inc. | Access and closure device and method |
US8083767B2 (en) | 2005-05-12 | 2011-12-27 | Arstasis, Inc. | Access and closure device and method |
US8241325B2 (en) | 2005-05-12 | 2012-08-14 | Arstasis, Inc. | Access and closure device and method |
US20070106246A1 (en) * | 2005-05-12 | 2007-05-10 | Modesitt D B | Access and closure device and method |
US11103146B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Wireless sensor for measuring pressure |
US11179048B2 (en) | 2005-06-21 | 2021-11-23 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | System for deploying an implant assembly in a vessel |
US11103147B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Method and system for determining a lumen pressure |
US11684276B2 (en) | 2005-06-21 | 2023-06-27 | Tc1, Llc | Implantable wireless pressure sensor |
US11890082B2 (en) | 2005-06-21 | 2024-02-06 | Tc1 Llc | System and method for calculating a lumen pressure utilizing sensor calibration parameters |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US8951286B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor and anchoring system |
US9814454B2 (en) | 2005-07-05 | 2017-11-14 | Mitralign, Inc. | Tissue anchor and anchoring system |
US20070010857A1 (en) * | 2005-07-05 | 2007-01-11 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US10695046B2 (en) | 2005-07-05 | 2020-06-30 | Edwards Lifesciences Corporation | Tissue anchor and anchoring system |
US9259218B2 (en) | 2005-07-05 | 2016-02-16 | Mitralign, Inc. | Tissue anchor and anchoring system |
US20090076547A1 (en) * | 2005-07-05 | 2009-03-19 | Mitralign, Inc. | Tissue anchor and anchoring system |
US20070078302A1 (en) * | 2005-08-05 | 2007-04-05 | Ortiz Mark S | Method and apparatus for sealing a gastric opening |
US8029522B2 (en) * | 2005-08-05 | 2011-10-04 | Ethicon Endo-Surgery, Inc. | Method and apparatus for sealing a gastric opening |
US20070203517A1 (en) * | 2005-09-27 | 2007-08-30 | Williams Michael S | Transgastric surgical devices and procedures |
EP2117423A2 (en) * | 2007-01-26 | 2009-11-18 | Endotronix, Inc. | Vascular closure device having sensor |
US8894582B2 (en) | 2007-01-26 | 2014-11-25 | Endotronix, Inc. | Cardiac pressure monitoring device |
EP2117423A4 (en) * | 2007-01-26 | 2011-11-09 | Endotronix Inc | Vascular closure device having sensor |
US9554783B2 (en) | 2007-02-01 | 2017-01-31 | Cook Medical Technologies Llc | Closure device and method of closing a bodily opening |
US9332977B2 (en) | 2007-02-01 | 2016-05-10 | Cook Medical Technologies Llc | Closure device |
US20100030259A1 (en) * | 2007-02-01 | 2010-02-04 | Dusan Pavcnik | Closure Device and Method of Closing a Bodily Opening |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
US8911461B2 (en) | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US9358111B2 (en) | 2007-03-13 | 2016-06-07 | Mitralign, Inc. | Tissue anchors, systems and methods, and devices |
US20080228198A1 (en) * | 2007-03-13 | 2008-09-18 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US20080281212A1 (en) * | 2007-03-15 | 2008-11-13 | Nunez Anthony I | Transseptal monitoring device |
US8493187B2 (en) | 2007-03-15 | 2013-07-23 | Endotronix, Inc. | Wireless sensor reader |
US9721463B2 (en) | 2007-03-15 | 2017-08-01 | Endotronix, Inc. | Wireless sensor reader |
US10003862B2 (en) | 2007-03-15 | 2018-06-19 | Endotronix, Inc. | Wireless sensor reader |
US9489831B2 (en) | 2007-03-15 | 2016-11-08 | Endotronix, Inc. | Wireless sensor reader |
US20100308974A1 (en) * | 2007-03-15 | 2010-12-09 | Rowland Harry D | Wireless sensor reader |
US9305456B2 (en) | 2007-03-15 | 2016-04-05 | Endotronix, Inc. | Wireless sensor reader |
US8154389B2 (en) | 2007-03-15 | 2012-04-10 | Endotronix, Inc. | Wireless sensor reader |
US9894425B2 (en) | 2007-03-15 | 2018-02-13 | Endotronix, Inc. | Wireless sensor reader |
US20090105744A1 (en) * | 2007-10-17 | 2009-04-23 | Modesitt D Bruce | Methods for forming tracts in tissue |
US20090221915A1 (en) * | 2008-03-03 | 2009-09-03 | Ethicon Endo-Surgery, Inc. | Transluminal tissue markers |
US8792966B2 (en) | 2008-03-03 | 2014-07-29 | Ethicon Endo-Surgery, Inc. | Transluminal tissue markers |
WO2009117435A3 (en) * | 2008-03-17 | 2009-11-26 | Northwestern University | Devices and methods for percutaneous access, hemostasis, and closure |
US20110040324A1 (en) * | 2008-03-17 | 2011-02-17 | Mccarthy Patrick M | Devices and methods for percutaneous access, hemostasis, and closure |
WO2009117435A2 (en) * | 2008-03-17 | 2009-09-24 | Northwestern University | Devices and methods for percutaneous access, hemostasis, and closure |
US9554787B2 (en) | 2008-03-17 | 2017-01-31 | Northwestern University | Devices and methods for percutaneous access, hemostasis, and closure |
US20150223801A1 (en) * | 2008-05-19 | 2015-08-13 | Ams Research Corporation | Collapsible Tissue Anchor Device and Method |
US9888912B2 (en) * | 2008-05-19 | 2018-02-13 | Boston Scientific Scimed, Inc. | Collapsible tissue anchor device and method |
US20090287229A1 (en) * | 2008-05-19 | 2009-11-19 | Ams Research Corporation | Collapsible Tissue Anchor Device and Method |
US9017382B2 (en) * | 2008-05-19 | 2015-04-28 | Ams Research Corporation | Collapsible tissue anchor device and method |
US20100016786A1 (en) * | 2008-07-21 | 2010-01-21 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
US8979882B2 (en) | 2008-07-21 | 2015-03-17 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
US20100016810A1 (en) * | 2008-07-21 | 2010-01-21 | Arstasis. Inc., | Devices and methods for forming tracts in tissue |
US8945211B2 (en) | 2008-09-12 | 2015-02-03 | Mitralign, Inc. | Tissue plication device and method for its use |
US20100100107A1 (en) * | 2008-10-20 | 2010-04-22 | IMDS, Inc. | Systems and methods for cerebrospinal fluid repair |
WO2010048189A2 (en) * | 2008-10-20 | 2010-04-29 | IMDS, Inc. | Systems and methods for cerebrospinal fluid repair |
US8992568B2 (en) | 2008-10-20 | 2015-03-31 | Neil Duggal | Systems and methods for cerebrospinal fluid repair |
WO2010048189A3 (en) * | 2008-10-20 | 2010-08-12 | IMDS, Inc. | Systems and methods for cerebrospinal fluid repair |
US20110125178A1 (en) * | 2009-05-15 | 2011-05-26 | Michael Drews | Devices, methods and kits for forming tracts in tissue |
US20110208215A1 (en) * | 2009-09-22 | 2011-08-25 | Modesitt D Bruce | Devices, methods, and kits for forming tracts in tissue |
US20120022562A1 (en) * | 2010-07-23 | 2012-01-26 | Boston Scientific Scimed, Inc. | Device to detect internal bleeding |
US20120035644A1 (en) * | 2010-08-03 | 2012-02-09 | Eskaros Sherif A | Tissue Plug |
US11064985B2 (en) | 2010-08-03 | 2021-07-20 | W. L. Gore & Associates, Inc. | Tissue plug |
US9023074B2 (en) | 2010-10-15 | 2015-05-05 | Cook Medical Technologies Llc | Multi-stage occlusion devices |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US10441753B2 (en) | 2012-05-25 | 2019-10-15 | Arstasis, Inc. | Vascular access configuration |
US10675447B2 (en) | 2012-05-25 | 2020-06-09 | Arstasis, Inc. | Vascular access configuration |
US10206592B2 (en) | 2012-09-14 | 2019-02-19 | Endotronix, Inc. | Pressure sensor, anchor, delivery system and method |
US20140222065A1 (en) * | 2013-02-01 | 2014-08-07 | St. Jude Medical Puerto Rico Llc | Hemostasis devices, components for hemostasis devices, and related methods |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US10154835B2 (en) | 2013-05-09 | 2018-12-18 | Essential Medical, Inc. | Vascular closure device with conforming plug member |
US10918373B2 (en) | 2013-08-31 | 2021-02-16 | Edwards Lifesciences Corporation | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10282571B2 (en) | 2015-09-02 | 2019-05-07 | Endotronix, Inc. | Self test device and method for wireless sensor reader |
US9996712B2 (en) | 2015-09-02 | 2018-06-12 | Endotronix, Inc. | Self test device and method for wireless sensor reader |
US11461568B2 (en) | 2017-02-24 | 2022-10-04 | Endotronix, Inc. | Wireless sensor reader assembly |
US11615257B2 (en) | 2017-02-24 | 2023-03-28 | Endotronix, Inc. | Method for communicating with implant devices |
US10430624B2 (en) | 2017-02-24 | 2019-10-01 | Endotronix, Inc. | Wireless sensor reader assembly |
US10814980B2 (en) | 2017-09-02 | 2020-10-27 | Precision Drone Services Intellectual Property, Llc | Distribution assembly for an aerial vehicle |
US11718400B2 (en) | 2017-09-02 | 2023-08-08 | Precision Drone Services Intellectual Property, Llc | Distribution assembly for an aerial vehicle |
CN109464172A (en) * | 2018-12-05 | 2019-03-15 | 江研伟 | Dura mater closed system and its application method under a kind of scope |
EP4014843A1 (en) * | 2020-12-16 | 2022-06-22 | HoliStick Medical | Medical implant and method of measuring a parameter |
WO2022129232A1 (en) * | 2020-12-16 | 2022-06-23 | Holistick Medical | Medical implant and method of measuring a parameter |
Also Published As
Publication number | Publication date |
---|---|
WO2005013832A1 (en) | 2005-02-17 |
US20080097522A1 (en) | 2008-04-24 |
US8292917B2 (en) | 2012-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8292917B2 (en) | Medical closure device | |
US7011647B2 (en) | Introducer sheath | |
US8491620B2 (en) | Dilator with expandable member | |
CA2557885C (en) | Occlusion balloon catheter with external inflation lumen | |
EP1379311B1 (en) | Microcatheter with improved distal tip and transitions | |
EP1797922B1 (en) | Microcatheter with improved distal tip and transitions | |
CA2813067C (en) | Distal access aspiration guide catheter | |
US6045734A (en) | Process of making a catheter | |
EP1789124B1 (en) | Catheter incorporating a guidewire exit ramp | |
US20070083252A1 (en) | Method for placing a stent through a constricted lumen, and medical device | |
JP2001218851A (en) | Catheter | |
CN113520549A (en) | Puncture instrument | |
EP3451955B1 (en) | Vascular access devices | |
US20060116636A1 (en) | Self-sealing catheter for deformable tissue | |
US20220184366A1 (en) | Vascular access sheath and catheter system | |
EP1703934B1 (en) | Catheter incorporating an improved polymer shaft | |
CN216876521U (en) | Puncture instrument | |
US20070073377A1 (en) | Method for placing a stent through a constricted lumen, and medical device | |
WO2020096945A1 (en) | Devices for assisting with advancement catheters and related systems and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHOPRA, GOPAL;REEL/FRAME:014381/0795 Effective date: 20030804 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |